Follow the Pundits
Tag: ARKK
ARKK 2025: The “Mojo” Is Back (But the Volatility Never Left)
ARKK crushed 2025, face-planted in early 2026, and reminded everyone why Cathie Wood’s fund is the wildest ride in innovation investing. Fun, data-driven, and brutally honest about the volatility.
Revisiting The Case of CRISPR Therapeutics: Still Crisp, Still Risky, Still Dangerously Alluring
CRISPR Therapeutics (CRSP) has the first widely approved CRISPR-based therapy, huge insider buying near today’s price, and institutions (including ARK) deep in the name — while shorts pile on. Crisp setup, risky execution, dangerously alluring upside. 🧬🎯
Coinbase: Betting Big on the Future of Digital Dollars
With $2 billion in quarterly revenue, a S&P 500 nod, and a crypto empire-in-the-making, Coinbase may be the most legit bet on the digital finance revolution. But with volatility still the name of the game, is this a long-term core holding—or a speculative moonshot with baggage? 🚀💸🧨